Tue, June 28, 2022
Mon, June 27, 2022
Fri, June 24, 2022
Thu, June 23, 2022
Wed, June 22, 2022
Tue, June 21, 2022
Sun, June 19, 2022
Fri, June 17, 2022

Paul Matteis Downgraded (ATHA) to Hold and Decreased Target to $5 on, Jun 23rd, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-5-on-jun-23rd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Paul Matteis of Stifel, Downgraded "Athira Pharma, Inc." (ATHA) to Hold and Decreased Target from $36 to $5 on, Jun 23rd, 2022.

Paul has made no other calls on ATHA in the last 4 months.



There are 2 other peers that have a rating on ATHA. Out of the 2 peers that are also analyzing ATHA, 0 agree with Paul's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Paul


  • Thomas Shrader of "BTIG" Initiated at Strong Buy and Held Target at $33 on, Tuesday, May 10th, 2022
  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $33 on, Thursday, April 21st, 2022